Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bolli

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium antagonists alone or in combination in today's antihypertensive therapyA Amery, P Bolli, C Dollery, et al.
The American Journal of Cardiology|December 6, 1985
Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonistsW Kiowski, F R Bühler, M O Fadayomi, et al.
The Canadian Journal of Cardiology|December 31, 1997
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoringF H Leenen, T W Wilson, P Bolli, et al.
Pharmacological Research Communications|September 1, 1988
Pathophysiological role of atrial natriuretic peptide in manF R Bühler, F B Müller, A E Raine, et al.
Journal of Medical Genetics|July 19, 2008
Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysmB Giusti, C Saracini, P Bolli, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humansP Bolli, F B Müller, L Linder, et al.
Thrombosis and Haemostasis|May 1, 1994
Serum lipid profile determines platelet reactivity to native and modified LDL-cholesterol in humansP L Katzman, R Bose, S Henry, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1987
Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensivesP Bolli, F B Müller, L Linder, et al.
British Journal of Clinical Pharmacology|January 1, 1985
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once dailyF B Müller, L F Allsopp, G L Cooper, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 13, 2009
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndromeC Fatini, E Sticchi, P Bolli, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium antagonists alone or in combination in today's antihypertensive therapyA Amery, P Bolli, C Dollery, et al.
The American Journal of Cardiology|December 6, 1985
Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonistsW Kiowski, F R Bühler, M O Fadayomi, et al.
The Canadian Journal of Cardiology|December 31, 1997
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoringF H Leenen, T W Wilson, P Bolli, et al.
Pharmacological Research Communications|September 1, 1988
Pathophysiological role of atrial natriuretic peptide in manF R Bühler, F B Müller, A E Raine, et al.
Journal of Medical Genetics|July 19, 2008
Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysmB Giusti, C Saracini, P Bolli, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humansP Bolli, F B Müller, L Linder, et al.
Thrombosis and Haemostasis|May 1, 1994
Serum lipid profile determines platelet reactivity to native and modified LDL-cholesterol in humansP L Katzman, R Bose, S Henry, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1987
Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensivesP Bolli, F B Müller, L Linder, et al.
British Journal of Clinical Pharmacology|January 1, 1985
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once dailyF B Müller, L F Allsopp, G L Cooper, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 13, 2009
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndromeC Fatini, E Sticchi, P Bolli, et al.
Pageof 13